Actelis Networks (ASNS) hit with Nasdaq delisting move after bid-price rule violation
Rhea-AI Filing Summary
Actelis Networks, Inc. reported that Nasdaq staff has determined to delist its common stock from The Nasdaq Capital Market. Nasdaq cited the Company’s failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days, breaching Nasdaq Listing Rule 5550(a)(2).
The notice states that Actelis is not eligible for the usual 180‑day cure period under Rule 5810(c)(3)(A)(iv) because it completed a 1‑for‑10 reverse stock split on November 18, 2025. Actelis plans to timely request a hearing before an independent Nasdaq Hearings Panel, which would stay any suspension or delisting action while the hearings process is underway.
Positive
- None.
Negative
- Nasdaq staff determination to delist common stock from The Nasdaq Capital Market after failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days, removing the usual 180‑day cure period due to a recent 1‑for‑10 reverse stock split.
Insights
Nasdaq moves to delist Actelis after bid-price noncompliance; hearing request will temporarily stay action.
Nasdaq staff has determined that Actelis Networks should be delisted from The Nasdaq Capital Market because its common stock did not meet the $1.00 minimum bid price requirement for 30 consecutive business days, violating Listing Rule 5550(a)(2). This directly affects the stock’s exchange listing status.
Normally, issuers receive a 180‑day grace period to regain compliance, but Nasdaq applied Rule 5810(c)(3)(A)(iv) since Actelis executed a 1‑for‑10 reverse stock split on November 18, 2025. Because of that recent split, the company faces immediate delisting rather than a standard cure period.
Actelis intends to request a hearing before an independent Nasdaq Hearings Panel, which the notice explains will stay any suspension or delisting action until the hearings process concludes. The eventual outcome will depend on the panel’s decision and any additional steps disclosed in future company filings.
8-K Event Classification
FAQ
What did Actelis Networks (ASNS) disclose about its Nasdaq listing status?
Why is Actelis Networks (ASNS) not getting a 180-day compliance period from Nasdaq?
How does Actelis Networks (ASNS) plan to respond to the Nasdaq delisting notice?
What role does the Nasdaq Hearings Panel play in the Actelis Networks (ASNS) case?